https://www.indianpharmapost.com/syngene-q2-fy23-24-revenue-from-operations-up-185-to-rs-910-cr-147972023-10-18T00:00:00+05:30always0.9https://www.indianpharmapost.com/glenmark-to-launch-a-triple-drug-fdc-of-teneligliptin-dapagliflozin-metformin-in-india-for-type-2-diabetes-147982023-10-18T00:00:00+05:30always0.9https://www.indianpharmapost.com/usfda-inspection-at-biocon-biologics-manufacturing-facility-in-johor-malaysia-147992023-10-18T00:00:00+05:30always0.9https://www.indianpharmapost.com/shilpa-medicare-unit-iv-jadcherla-has-cleared-tga-australia-gmp-inspection-148002023-10-18T00:00:00+05:30always0.9https://www.indianpharmapost.com/glenmark-receives-anda-approval-for-apremilast-tablets-148012023-10-18T00:00:00+05:30always0.9